Abivax annual total assets
2021
2022
2023
2024
2025
Abivax Total Assets Growth & History (ABVX)
Abivax's total assets was €584.3M for fiscal 2025.
View full Abivax company overviewAbivax annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €584.3M | €379.1M | +184.73% |
| 2024 | 2024-12-31 | €205.2M | −€121.8M | −37.25% |
| 2023 | 2023-12-31 | €327.1M | €251.5M | +332.94% |
| 2022 | 2022-12-31 | €75.5M | −€33.7M | −30.84% |
| 2021 | 2021-12-31 | €109.2M | — | — |
Abivax quarterly total assets
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | €547.1M | €380.2M | +227.75% |
| Q4 2025 | 2025-12-31 | €584.3M | €379.1M | +184.73% |
| Q3 2025 | 2025-09-30 | €652.1M | — | — |
| Q2 2025 | 2025-06-30 | €119.6M | — | — |
| Q1 2025 | 2025-03-31 | €166.9M | — | — |
| Q4 2024 | 2024-12-31 | €205.2M | — | — |
Abivax total assets trends
Between the periods ended 2021-12-31 and 2025-12-31, Abivax's total assets increased from €109.2M to €584.3M, a change of €475.1M. The latest reported quarter, Q1 2026, shows €547.1M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Abivax source filings ↗